ランキング価格はじめての方へ
  1. 米国企業
  2. ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC.ABEO

時価総額
$1.4億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日
Net loss-2,532,000-10,532,0004-26,778,000-14,526,000-21,873,000-27,319,000-56,671,000-76,282,000-84,234,000-84,936,000-40
Depreciation and amortization233,000419,0003,00011,000551,000825,000741,00028533
Stock-based compensation expense-----5587653
Gain on settlement with licensor----------7-
PPP loan payable forgiveness income----------2-
Impairment of goodwill----------32-
Change in fair value of warrant liabilities------------11
Impairment of licensed technology-----------1
Impairment of right-of-use lease assets-----------3
Non-cash impairment of construction-in-progress-----------2
Accretion and interest on short-term investments-----------0
Amortization of right-of-use lease assets----------11
Non-cash interest-----------1
Loss on disposal of property and equipment------------0
Gain on lease termination-----------0
Accounts receivable------------3
Other receivables-----------0
Prepaid expenses and other current assets-31,000212,000-174,000-77,000287,000-160,00031-670,000-424,000-331,000-2
Other assets15,000-17,000-10,000-29,0004,000---3,000127,0007,000-0
Accounts payable, accrued expenses and lease liabilities53,000567,000-1,176,00033,000-1,174,000-------5
Deferred revenue-1,180,000-596,0003-349,000-602,000-602,0002296,000----0
Change in payable to licensor------------5
Net cash used in operating activities-7,609,000-3,955,0001,000----22,935,000-39,111,000-62,820,000-35,019,000-66-43
Capital expenditures40,00013,0002,000-308,000519,000860,00096140
Proceeds from disposal of property and equipment----4------2
Purchases of short-term investments---------1702078
Proceeds from maturities of short-term investments--------66889053
Net cash (used in) provided by investing activities-40,000-13,000-2,000----860,000-85,086,00060-83,714,00066-24
Proceeds from ATM sales of common stock, net of issuance costs6--127---17-813
Proceeds from issuance of common stock and warrants in private offering, net of issuance costs-----------34
Proceeds from exercise of stock options and net settlement of restricted share awards------------0
Proceeds from issuance of Series A and Series B Convertible Redeemable Preferred Stock, net of issuance costs-----------23
Redemption of Series A and Series B Convertible Redeemable Preferred Stock-----------26
Net cash provided by financing activities3229,000---92511422543
Net (decrease)increase in cash, cash equivalents and restricted cash--------118,720,000111-116,797,00025-24
Additions (deletions) to right-of-use lease assets obtained from new operating lease liabilities resulting from modification of original lease arrangement----------4-0
Deletions to operating lease liabilities obtained from new operating lease liabilities resulting from modification of original lease arrangement------------0